Supplementary Figure S2: Effect of ipilimumab on CD4+ cells and CD8+ cells in bladder and prostate tumors from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3&lt;sup&gt;+&lt;/sup&gt; Regulatory T Cells (Tregs) in Human Cancers